Latest Ratios: P/E Ratio -75.3x · EV/EBITDA 392.4x · ROE -8.2%. (2020–2024 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Market Cap | $2.5B | $2.4B | $1.5B | — | — | — |
| Enterprise Value | $2.8B | $2.6B | $1.6B | — | — | — |
| P/E Ratio → | -75.31 | — | 157.88 | — | — | — |
| P/S Ratio | 22.35 | 21.28 | 21.98 | — | — | — |
| P/B Ratio | 4.28 | 5.63 | 8.89 | — | — | — |
| P/FCF | — | — | — | — | — | — |
| P/OCF | — | — | — | — | — | — |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| EV / Revenue | — | 23.55 | 23.72 | — | — | — |
| EV / EBITDA | 392.45 | 375.37 | 57.21 | — | — | — |
| EV / EBIT | — | — | 77.34 | — | — | — |
| EV / FCF | — | — | — | — | — | — |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Gross Margin | 89.8% | 89.8% | 90.2% | 86.8% | 37.1% | 58.0% |
| Operating Margin | -0.8% | -0.8% | 36.3% | 75.3% | 4.1% | 110.3% |
| Net Profit Margin | -21.4% | -21.4% | 14.3% | 70.9% | 4.4% | 54.1% |
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| ROE | -8.2% | -8.2% | 9.9% | 219.1% | 96.5% | 50.9% |
| ROA | -4.0% | -4.0% | 4.9% | 104.0% | 60.4% | 45.3% |
| ROIC | -0.1% | -0.1% | 11.8% | 177.8% | 46.4% | 77.1% |
| ROCE | -0.2% | -0.2% | 13.2% | 114.8% | 87.4% | 103.9% |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Debt / Equity | 0.91 | 0.91 | 0.86 | 1.02 | 1.37 | 0.11 |
| Debt / EBITDA | 54.96 | 54.96 | 5.15 | 0.85 | 1.09 | 0.23 |
| Net Debt / Equity | — | 0.60 | 0.71 | -0.05 | 1.24 | 0.01 |
| Net Debt / EBITDA | 36.17 | 36.17 | 4.22 | -0.04 | 0.98 | 0.02 |
| Debt / FCF | — | — | — | — | 0.85 | 0.02 |
| Interest Coverage | -0.05 | -0.05 | 2.45 | 786.61 | — | — |
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Current Ratio | 2.55 | 2.55 | 1.36 | 25.55 | 0.20 | 1.31 |
| Quick Ratio | 2.55 | 2.55 | 1.36 | 25.55 | 0.20 | 1.31 |
| Cash Ratio | 2.11 | 2.11 | 1.19 | 23.07 | 0.10 | 0.84 |
| Asset Turnover | — | 0.13 | 0.20 | 0.76 | 12.28 | 0.84 |
| Inventory Turnover | — | — | — | — | — | — |
| Days Sales Outstanding | — | — | — | — | — | — |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — |
| Payout Ratio | — | — | — | 2.1% | 35.9% | 49.5% |
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Earnings Yield | — | — | 0.6% | — | — | — |
| FCF Yield | — | — | — | — | — | — |
| Buyback Yield | 0.4% | 0.5% | 1.7% | — | — | — |
| Total Shareholder Yield | 0.4% | 0.5% | 1.7% | — | — | — |
| Shares Outstanding | — | $71M | $58M | $30M | $43M | $43M |
Fair value accounting volatility
Based on reported figures, Abacus Life trades at a P/B multiple of 4.28, which significantly exceeds the peer group average, suggesting that investors are pricing in aggressive future scale rather than current book value stability or consistent underwriting profitability in the life settlement market.
The elevated P/B ratio appears to reflect market optimism regarding the firm's proprietary origination platform and its potential to capture long-term value from its policy portfolio. However, given the negative net margins and historical earnings volatility, this valuation premium warrants caution as it relies heavily on the assumption that future policy maturities will eventually justify the current capital intensity.
As reported in quarterly financial filings, the combined ratio has exhibited extreme volatility, ranging from a low of 26.4% in 2023Q2 to a peak of 150.5% in 2024Q4, indicating that underwriting performance is currently inconsistent and highly sensitive to the timing of policy maturities.
The fluctuation in the combined ratio suggests that the firm's underwriting results are heavily influenced by non-cash fair value adjustments rather than steady-state operational efficiency. Investors should monitor whether the recent stabilization in the 50-60% range represents a sustainable trend or merely a temporary period of favorable mortality outcomes.
According to recent financial statements, the company's D/E ratio has fluctuated significantly, reaching 0.28 in 2025Q3, which highlights the firm's reliance on external financing to support its aggressive policy acquisition strategy and maintain its current growth trajectory in a capital-intensive industry.
While the current leverage profile appears manageable, the necessity of maintaining a large portfolio of policies to maturity requires consistent access to capital. Any tightening in credit markets or a sustained increase in the cost of debt could place significant pressure on the firm's ability to fund future policy acquisitions.
As indicated by the discrepancy between net income and operational performance, the reliance on ASC 820 fair value accounting may be masking the true liquidity profile of the firm, as non-cash unrealized gains often drive headline earnings while mandatory premium payments represent a persistent cash outflow.
The combined ratio is frequently misapplied to Abacus Life because it fails to account for the unique nature of life settlement assets, where fair value adjustments can create artificial volatility. Analysts should prioritize cash-adjusted metrics over traditional underwriting ratios to better understand the actual liquidity and long-term viability of the business model.
Includes 30+ ratios · 5 years · Updated daily
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying ABLLL stock.
Abacus Life, Inc. 9.875% Fixed Rate Senior Notes due 2028's current P/E ratio is -75.3x. The historical average is 157.9x.
Abacus Life, Inc. 9.875% Fixed Rate Senior Notes due 2028's current EV/EBITDA is 392.4x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 57.2x.
Abacus Life, Inc. 9.875% Fixed Rate Senior Notes due 2028's return on equity (ROE) is -8.2%. The historical average is 73.7%.
Based on historical data, Abacus Life, Inc. 9.875% Fixed Rate Senior Notes due 2028 is trading at a P/E of -75.3x. Compare with industry peers and growth rates for a complete picture.
Abacus Life, Inc. 9.875% Fixed Rate Senior Notes due 2028 has 89.8% gross margin and -0.8% operating margin.
Abacus Life, Inc. 9.875% Fixed Rate Senior Notes due 2028's Debt/EBITDA ratio is 55.0x, indicating high leverage. A ratio above 4x may signal elevated financial risk.